Skip to content
Opinion
Clara Ferreira Marques

What Will It Take to Vaccinate the World?

A Q&A with vaccine scientist Peter Hotez, author of “Preventing the Next Pandemic,” on developing a low-cost Covid-19 vaccine, combating vaccine disinformation and why omicron won’t be the end of the pandemic.   

Low-cost vaccines are key to preventing the emergence of new variants.      

Low-cost vaccines are key to preventing the emergence of new variants.      

Photographer: Prakash Singh/AFP

This is one of a series of interviews by Bloomberg Opinion columnists on how to solve the world’s most pressing policy challenges. It has been edited for length and clarity.

Clara Ferreira Marques:  You’re a veteran advocate for global health, vaccines and tropical-disease control, and served as a U.S. science envoy during the Obama administration. You’ve now developed a low-cost Covid-19 vaccine, Corbevax, using a tried-and-tested method. It’s a recombinant protein vaccine, which means it should be easy to scale. The technology will be available for anyone to reproduce. How do you expect it to contribute to global vaccination efforts?